Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple blood test could uncover hidden diabetes in ER patients

NCT ID NCT04653545

Diagnosis Sponsor: Tameside General Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at over 5,000 adults coming to the emergency room to see how many had undiagnosed type 2 diabetes or pre-diabetes. Researchers used a standard HbA1c blood test, already taken for other reasons, to screen patients. The goal was to find out how common hidden diabetes is in this setting and whether routine screening could help start treatment earlier.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
HbA1c blood test
What this could lead to
If successful, this could lead to a simple, routine screening method to catch hidden diabetes early in emergency room patients, potentially improving long-term health outcomes.
What could go wrong
This is a completed observational study, not a treatment trial. It only measures how common undiagnosed diabetes is; it does not test a new therapy or prove that screening improves outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

5,050 people

The number who actually took part.

Started

Feb 2022

Finished

Apr 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients attending the accident and emergency department and acute medical wards of a district general hospital

Ages

30 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged ≥30 years. * Males and female sex Exclusion Criteria: * Aged \<30 years. * Type 1 diabetes

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabete type 2 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabete type 2

Contacts and locations

Locations

  • Tameside Hospital NHS Foundation Trust

    Ashton-under-Lyne, Greater Manchester, OL6 9RW, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.